DENVER and PHOENIX, March 18, 2016 -- Dixie Brands, Inc. (Dixie), a leader in emerging cannabinoid extraction and wellness platforms, has launched the first phase of its joint venture with Bloom Dispensaries. The initial products available for sale today, includes the complete line of Dixie branded topical products as well as Dixie Brands' two new hemp-derived cannabinoid wellness platforms, Aceso a human wellness product line and Therabis, designed to serve pets. Dixie Brands Arizona will begin delivering these products to dispensaries throughout the state on March 21, 2016.
"Dixie is thrilled to deliver our full line of medical topicals, as well as our non-THC cannabinoid therapy products, to the patients in Arizona," said Tripp Keber, President and CEO of Dixie Brands, Inc. "Developed in Colorado, and powered by local Arizona grown cannabis, our three unique topical products combine THC with natural ingredients and organic oils to soothe and calm aches and pains from the skin, inward. Education about topicals and their benefits is a crucial element of this roll out as this product is ideal for patients who are looking for very effective pain relief without the euphoria or high normally associated with THC."
The initial launch will introduce Dixie's full topical product line, including their signature Relief Balm, Muscle Relief Lotion and Bath Soak. Developed over five years by Dixie's innovative science team in Colorado, these diverse topicals are a great way to treat localized skin irritation, joint pain and muscle aches.
"Today's announcement is the first of many milestones we expect to achieve as we work to bring the complete line of Dixie Elixirs and Edibles products to Arizona patients as quickly as our commercial state of the art manufacturing facility construction will allow," said Edward Judice, CEO of Bloom. "We view today's initial product launch as a great win for the Arizona medical marijuana community, who can benefit from the years of research and development that Dixie has invested in their products in order to deliver the product quality and consistency that Arizona patients deserve."
MSRP for the new products is as follows (but will vary by dispensary):
- Dixie 90MG Relief Balm: $14
- Dixie 90MG Pain Relief Lotion: $14
- Dixie 90MG Bath Soak: $16
|
|||||
Want to learn more about the benefits of topical THC uptake? Visit Dixie's Uptake System Education Page.
ABOUT DIXIE BRANDS, INC.
Located in Denver, Colorado, Dixie Brands, Inc., (Dixie) through its affiliates across the country, has been formulating and producing award-winning THC and CBD-infused products since 2009. What began as a single flagship product, the Dixie Elixir (a THC-infused soda), has now expanded to over 30 different products across over 100 SKUs, representing the industry's finest edibles, tinctures, topicals and connoisseur grade extractions. In addition, Dixie Brands has launched two new cannabinoid product lines: Aceso, is a suite of "hemp 2.0" products designed to provide general wellness and relief from minor aches and pains as well as mild-anxiety. Therabis is a pet supplement formulated by an experienced veterinarian and designed to provide pets, and their owners, with relief from itching and mild-anxiety as well as providing greater joint mobility. To find out more about Dixie's innovative products, or about how Dixie is building the future of cannabis, please visit us at http://www.dixiebrands.com.
CONTACT
Joe Hodas
Dixie Brands, Chief Marketing Officer
[email protected]
303-827-6972
A photo accompanying this release is available at: http://www.globenewswire.com/newsroom/prs/?pkgid=39494
CONTACT: Joe Hodas
Dixie Brands, Chief Marketing Officer
[email protected]
303-827-6972


Indonesia and Toyota Explore $300M Bioethanol Investment to Boost Renewable Energy Goals
Rising Jet Fuel Costs from Iran Conflict Push Airfare Higher Across Europe
Want to cut your energy bills? Here’s how five experts are doing it
Chinese Robotics Stocks React as Humanoid Robot Marathon Sparks Competition Concerns
Nidec Stock Rises After Accounting Probe Report Eases Delisting Concerns
Huawei Expands Vietnam Presence Through Strategic Partnership with SHB Bank
Eli Lilly in Talks to Acquire Kelonia Therapeutics for Over $2 Billion
SpaceX President Gwynne Shotwell Earns $85.8M as IPO Buzz Grows
Elon Musk Faces French Probe Over X and Grok Amid Rising U.S.-EU Tensions
Amazon Expands AI Bet with Up to $25 Billion Investment in Anthropic
Jeff Bezos Eyes $10 Billion Funding Round for AI Venture Project Prometheus
Ethiopian Airlines Expands Fleet with New Boeing 787 Dreamliner Order to Boost Global Routes
NVIDIA Acquisition Rumors Dismissed by Morgan Stanley as Strategically Flawed
Indian Refiners Use Yuan via ICICI Bank to Pay for Iranian Oil Under U.S. Sanctions Waiver
AEVEX Raises $320 Million in IPO Amid Surging Defense Sector Demand
Apple Stock Dips as Tim Cook Steps Down, John Ternus Named Next CEO
J.P. Morgan Downgrades Essity AB on Rising Costs and Weak Earnings Outlook 



